Tag: Prescription Drugs

Sustained treatment with semaglutide needed to maintain reduction in risk for type 2 diabetes

PFS improved with cabozantinib + nivolumab + ipilimumab for patients with previously untreated advanced renal cell carcinoma

Risk for maternal IBD relapse and prematurity reduced with continuation of anti-TNF after 24 weeks of pregnancy

Patients receiving bebtelovimab have more comorbidities, but do not have increased rates of progression to severe disease

Evening dosing of blood pressure medication no better than morning dosing

Agency says research in labs, animals, and people suggests that monkeypox could develop resistance to the antiviral in multiple ways

Signs and symptoms of atopic dermatitis improved with dupilumab versus placebo in addition to topical corticosteroids

New update strongly recommends against use of sotrovimab and casirivimab-imdevimab for patients with COVID-19

Overall risk-benefit ratio seems to favor patients receiving linezolid at dose of 600 mg for 26 weeks

In phase 2 study, about half of patients with resectable stage II to IV cutaneous squamous cell carcinoma had pathological complete response